Phase 1 Diabetic Kidney Disease Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease
healthy adult participantsDiabetic Kidney Disease
Mediar Therapeutics88 enrolled1 locationNCT07473323
Not Yet Recruiting
Phase 1
A Phase 1 Randomized, Double-blind, Dose-Escalating Study to Assess the Safety, Tolerability, and Pharmacokinetics of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease
Chronic Kidney DiseaseDiabetic Kidney Disease
Mediar Therapeutics88 enrolled1 locationACTRN12626000533392
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in DKD Patients
Diabetic Kidney Disease
Alebund Pharmaceuticals18 enrolled1 locationNCT06666283
Recruiting
Phase 1
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
Cardiovascular DiseasesEndothelial DysfunctionType 1 Diabetes+2 more
Kalie Tommerdahl60 enrolled2 locationsNCT05065372
Recruiting
Phase 1
Dosimetry of Tc-99m-Tilmanocept
Diabetic Kidney Disease
University of California, San Diego120 enrolled1 locationNCT05241522